Gut microbiota and the periodontal disease: role of hyperhomocysteinemia.

1-carbon metabolism bone resorption dysbiose dysbiosis homocysteine homocystéine métabolisme du 1-carbone probiotics probiotiques résorption osseuse

Journal

Canadian journal of physiology and pharmacology
ISSN: 1205-7541
Titre abrégé: Can J Physiol Pharmacol
Pays: Canada
ID NLM: 0372712

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 25 7 2020
medline: 21 9 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Periodontal disease is one of the most common conditions resulting from poor oral hygiene and is characterized by a destructive process in the periodontium that essentially includes gingiva, alveolar mucosa, cementum, periodontal ligament, and alveolar bone. Notably, the destructive event in the alveolar bone has been linked to homocysteine (Hcy) metabolism; however, it has not been fully investigated. Therefore; the implication of Hcy towards initiation, progression, and maintenance of the periodontal disease remains incompletely understood. Higher levels of Hcy (also known as hyperhomocysteinemia (HHcy)) exerts deleterious effects on gum health and teeth in distinct ways. Firstly, increased production of proinflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 leads to an inflammatory cascade of events that affect methionine (Met) and Hcy metabolism (i.e., 1-carbon metabolism) leading to HHcy. Secondly, metabolic dysregulation during chronic medical conditions increases systemic inflammation leading to a decrease in vitamins, more specifically B6, B12, and folic acid, that play important roles as cofactors in Hcy metabolism. Also, given the folate level in the HHcy state that is important during dysbiosis, these two conditions appear to be intimately related, and in this context, HHcy-induced dysbiosis may be one of the potential causes of periodontal disease. This paper sums up the link between periodontitis and HHcy, with a special emphasis on the "oral-gut microbiome axis" and the potential probiotic intervention towards warding off some of the serious periodontal disease conditions.

Identifiants

pubmed: 32706987
doi: 10.1139/cjpp-2020-0215
doi:

Substances chimiques

Homocysteine 0LVT1QZ0BA
Folic Acid 935E97BOY8
Methionine AE28F7PNPL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-17

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR071789
Pays : United States

Auteurs

Dragana Stanisic (D)

Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Milica Jovanovic (M)

Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Akash K George (AK)

Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Rubens P Homme (RP)

Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Neetu Tyagi (N)

Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Mahavir Singh (M)

Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Suresh C Tyagi (SC)

Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH